Literature DB >> 19706044

Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710.

P Nikpour1, S J Mowla, S M Jafarnejad, U Fischer, W A Schulz.   

Abstract

OBJECTIVES: The Nucleostemin (NS) gene encodes a nucleolar protein enriched in adult and embryonic stem cells. NS is thought to regulate cancer cell proliferation, but the mechanisms involved are poorly understood. In this study, we have investigated the role of NS in bladder cancer.
MATERIALS AND METHODS: Expression of NS was determined by quantitative reverse transcription-polymerase chain reaction in bladder carcinoma cell lines and in normal uro-epithelial cell cultures. We used an RNAi strategy to investigate the function of NS in two selected carcinoma cell lines.
RESULTS: High NS expression was found in most bladder carcinoma cell lines and normal uro-epithelial cells. Knockdown of NS expression induced a severe decline in cell proliferation in 5637 and SW1710 cell lines, both with mutant p53. Apoptosis was more strongly enhanced in 5637 cells lacking RB1 than in SW1710 cells lacking p16(INK4A). Moreover, NS-siRNA-treated 5637 cells accumulated mainly in G(2)/M, whereas SW1710 cells arrested in G(0)/G(1).
CONCLUSION: Our data indicate that NS expression is necessary for cell proliferation and evasion of apoptosis in bladder cancer cells, independent of its effect on p53. Also, we speculate that the precise effect of NS on cell cycle regulation may relate to functional status of RB1 and CDKN2A/p16(INK4A).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706044      PMCID: PMC6495913          DOI: 10.1111/j.1365-2184.2009.00635.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  34 in total

1.  TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin.

Authors:  A van Bokhoven; M Varella-Garcia; C Korch; G J Miller
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

2.  Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.

Authors:  Mu-Shui Dai; Xiao-Xin Sun; Hua Lu
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

3.  Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer.

Authors:  I D Markl; P A Jones
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

4.  Evolutionarily conserved role of nucleostemin: controlling proliferation of stem/progenitor cells during early vertebrate development.

Authors:  Chantal Beekman; Massimo Nichane; Sarah De Clercq; Marion Maetens; Thomas Floss; Wolfgang Wurst; Eric Bellefroid; Jean-Christophe Marine
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

Review 5.  Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.

Authors:  Anirban P Mitra; Ram H Datar; Richard J Cote
Journal:  J Clin Oncol       Date:  2006-12-10       Impact factor: 44.544

Review 6.  Tumor suppressor loci in bladder cancer.

Authors:  Margaret A Knowles
Journal:  Front Biosci       Date:  2007-01-01

7.  Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells.

Authors:  Ran-lu Liu; Zhi-hong Zhang; Wei-ming Zhao; Meng Wang; Shi-yong Qi; Jing Li; Yue Zhang; Sheng-zhi Li; Yong Xu
Journal:  Chin Med J (Engl)       Date:  2008-02-20       Impact factor: 2.628

8.  Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy.

Authors:  Abbas Jafari Kermani; Fardin Fathi; Seyed Javad Mowla
Journal:  Rejuvenation Res       Date:  2008-04       Impact factor: 4.663

9.  Nucleostemin mRNA is expressed in both normal and malignant renal tissues.

Authors:  Y Fan; Z Liu; S Zhao; F Lou; S Nilsson; P Ekman; D Xu; X Fang
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

10.  Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.

Authors:  K M Rieger; A F Little; J M Swart; W V Kastrinakis; J M Fitzgerald; D T Hess; J A Libertino; I C Summerhayes
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more
  18 in total

1.  Concomitant upregulation of nucleostemin and downregulation of Sox2 and Klf4 in gastric adenocarcinoma.

Authors:  Malek Hossein Asadi; Ali Derakhshani; Seyed Javad Mowla
Journal:  Tumour Biol       Date:  2014-04-25

2.  Nucleostemin depletion induces post-g1 arrest apoptosis in chronic myelogenous leukemia k562 cells.

Authors:  Negin Seyed-Gogani; Marveh Rahmati; Nosratollah Zarghami; Iraj Asvadi-Kermani; Mohammad Ali Hoseinpour-Feyzi; Mohammad Amin Moosavi
Journal:  Adv Pharm Bull       Date:  2013-12-23

3.  Turning a new page on nucleostemin and self-renewal.

Authors:  Robert Y L Tsai
Journal:  J Cell Sci       Date:  2014-08-15       Impact factor: 5.285

4.  Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening.

Authors:  Celia Conesa; Michael Xavier Doss; Charles Antzelevitch; Agapios Sachinidis; Javier Sancho; José Alberto Carrodeguas
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

5.  Nucleostemin and GNL3L exercise distinct functions in genome protection and ribosome synthesis, respectively.

Authors:  Tao Lin; Lingjun Meng; Tsung-Chin Lin; Laura J Wu; Thoru Pederson; Robert Y L Tsai
Journal:  J Cell Sci       Date:  2014-03-07       Impact factor: 5.285

6.  Guanine nucleotide binding protein-like 3 is a potential prognosis indicator of gastric cancer.

Authors:  Jing Chen; Shuang Dong; Jiangfeng Hu; Bensong Duan; Jian Yao; Ruiyun Zhang; Hongmei Zhou; Haihui Sheng; Hengjun Gao; Shunlong Li; Xianwen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Reactive oxygen species regulate nucleostemin oligomerization and protein degradation.

Authors:  Min Huang; Patrick Whang; Jayanth V Chodaparambil; Daniel A Pollyea; Brenda Kusler; Liwen Xu; Dean W Felsher; Beverly S Mitchell
Journal:  J Biol Chem       Date:  2011-01-17       Impact factor: 5.157

8.  Differential expression of ZFX gene in gastric cancer.

Authors:  Parvaneh Nikpour; Modjtaba Emadi-Baygi; Faezeh Mohammad-Hashem; Mohamad Reza Maracy; Shaghayegh Haghjooy-Javanmard
Journal:  J Biosci       Date:  2012-03       Impact factor: 1.826

9.  EYA1 expression in gastric carcinoma and its association with clinicopathological characteristics: a pilot study.

Authors:  Parvaneh Nikpour; Modjtaba Emadi-Baygi; Elaheh Emadi-Andani; Shima Rahmati
Journal:  Med Oncol       Date:  2014-04-12       Impact factor: 3.064

Review 10.  Balancing self-renewal against genome preservation in stem cells: How do they manage to have the cake and eat it too?

Authors:  Robert Y L Tsai
Journal:  Cell Mol Life Sci       Date:  2016-02-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.